A randomized, double-blind pilot study of a multi-strain probiotic formulation on depressive symptoms in adults
Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale · 29.04.2026 · 99 (1)
DOI: 10.4081/jbr.2026.14692 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale, online erschienen am 29.04.2026. Verfasst von Fabiana D'Urso und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Depression
Abstract (Originalsprache)
The gut–brain axis represents a bidirectional communication pathway influencing mood through microbiota-related mechanisms. This randomized, double-blind, active-controlled pilot trial evaluated the effects of a multi-strain Lactobacillus spp. probiotic formulation added to an active control on depressive symptoms in adults with mild-to-moderate depressive symptoms. Sixty participants were randomly assigned to receive either a daily combination containing L. rhamnosus HN001, L. rhamnosus SP1, L. acidophilus LA1, and L. reuteri LR92 (3×10⁹ CFU total) plus L-theanine and Eschscholtzia californica (probiotic group) or an identical active control containing L-theanine and E. californica alone for six weeks. Depressive symptoms were assessed using the Patient Health Questionnaire-9 (PHQ-9) and the Beck Depression Inventory-II at baseline, week 3, week 6, and after a three-week washout. Significant within-group reductions in depressive symptom scores were observed in the probiotic group, while changes in the active control group were smaller and not statistically significant. However, between-group comparisons did not reach statistical significance at any time point. These findings suggest that the probiotic-containing formulation was associated with improvements in depressive symptoms when administered on top of an active control. Due to the study design, effects cannot be attributed specifically to the probiotic component alone. Larger trials incorporating inert placebo controls and microbiome analyses are warranted.
Zitieren
APA
D'Urso, F., Paladini, F., Chieppa, M., Scoditti, E., Pollini, M., & Broccolo, F. (2026). A randomized, double-blind pilot study of a multi-strain probiotic formulation on depressive symptoms in adults. Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale, 99(1). https://doi.org/10.4081/jbr.2026.14692
Vancouver
D'Urso F, Paladini F, Chieppa M, Scoditti E, Pollini M, Broccolo F. A randomized, double-blind pilot study of a multi-strain probiotic formulation on depressive symptoms in adults. Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale. 2026;99(1). doi:10.4081/jbr.2026.14692
BibTeX
@article{DUrso2026,
author = {D'Urso, Fabiana and Paladini, Federica and Chieppa, Marcello and Scoditti, Egeria and Pollini, Mauro and Broccolo, Francesco},
title = {A randomized, double-blind pilot study of a multi-strain probiotic formulation on depressive symptoms in adults},
journal = {Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale},
year = {2026},
volume = {99},
number = {1},
doi = {10.4081/jbr.2026.14692}
}
EUVIMED